188 related articles for article (PubMed ID: 33948971)
1. Benefits and harms of hemithyroidectomy, total or near-total thyroidectomy in 1-4 cm differentiated thyroid cancer.
Xu Y; Huang K; Huang P; Ke N; Zeng J; Wang L; Liu C; Shi X; Guo F; Su L; Lin M; Li X; Xiao F
Clin Endocrinol (Oxf); 2021 Oct; 95(4):668-676. PubMed ID: 33948971
[TBL] [Abstract][Full Text] [Related]
2. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
3. Hemithyroidectomy versus total thyroidectomy in the intermediate-risk differentiated thyroid cancer: the Italian Societies of Endocrine Surgeons and Surgical Oncology Multicentric Study.
Dobrinja C; Samardzic N; Giudici F; Raffaelli M; De Crea C; Sessa L; Docimo G; Ansaldo GL; Minuto M; Varaldo E; Dionigi G; Spiezia S; Boniardi M; Pauna I; De Pasquale L; Testini M; Gurrado A; Pasculli A; Pezzolla A; Lattarulo S; Calò PG; Graceffa G; Massara A; Docimo L; Ruggiero R; Parmeggiani D; Iacobone M; Innaro N; Lombardi CP; de Manzini N
Updates Surg; 2021 Oct; 73(5):1909-1921. PubMed ID: 34435312
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract][Full Text] [Related]
5. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence.
Song E; Han M; Oh HS; Kim WW; Jeon MJ; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Sung TY; Kim WG
Thyroid; 2019 Jan; 29(1):64-70. PubMed ID: 30375260
[TBL] [Abstract][Full Text] [Related]
6. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
[No Abstract] [Full Text] [Related]
7. Survival after hemithyroidectomy versus total thyroidectomy in non-high-risk differentiated thyroid cancer: population-based analysis.
Liu X; Wong CKH; Chan WWL; Au ICH; Tang EHM; Lang BHH
BJS Open; 2022 Nov; 6(6):. PubMed ID: 36426588
[TBL] [Abstract][Full Text] [Related]
8. Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: a single-center experience.
Xue S; Wang P; Liu J; Chen G
World J Surg Oncol; 2017 Mar; 15(1):62. PubMed ID: 28302162
[TBL] [Abstract][Full Text] [Related]
9. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?
Dobrinja C; Pastoricchio M; Troian M; Da Canal F; Bernardi S; Fabris B; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S34-S39. PubMed ID: 28506411
[TBL] [Abstract][Full Text] [Related]
10. Extent of surgery did not affect recurrence during 7-years follow-up in papillary thyroid cancer sized 1-4 cm: Preliminary results.
Kim MJ; Lee MC; Lee GH; Choi HS; Cho SW; Kim SJ; Lee KE; Park YJ; Park DJ
Clin Endocrinol (Oxf); 2017 Jul; 87(1):80-86. PubMed ID: 28338234
[TBL] [Abstract][Full Text] [Related]
11. Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer.
Momesso DP; Vaisman F; Caminha LS; Pessoa CH; Corbo R; Vaisman M
J Endocrinol Invest; 2014 Jan; 37(1):57-64. PubMed ID: 24464451
[TBL] [Abstract][Full Text] [Related]
12. A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Song DE; Sung TY; Yoon JH; Hong SJ; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2017 Apr; 176(4):371-378. PubMed ID: 28089996
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics-Assisted Risk Stratification for Extent of Thyroidectomy in Patients With 1-4 cm Solitary Intrathyroidal Differentiated Thyroid Cancer.
Dong F; Zhou L; Wang S; Mao J; Liu C; Shi W
Front Endocrinol (Lausanne); 2021; 12():790730. PubMed ID: 35211090
[TBL] [Abstract][Full Text] [Related]
14. Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid Cancer Patients: Median Follow-Up of 11 Years.
Bal C; Satapathy S; Tupalli A; Ballal S
Thyroid; 2022 Oct; 32(10):1220-1228. PubMed ID: 35983596
[No Abstract] [Full Text] [Related]
15. Health-Related Quality of Life in Patients with Low-Risk Differentiated Thyroid Cancer: A Systematic Review Examining the Extent of Thyroidectomy.
Bach K; Ansari P; Ansari H; Mott NM; Elfenbein DM; Underwood H; Pitt SC
Thyroid; 2024 Jan; 34(1):14-25. PubMed ID: 37861284
[No Abstract] [Full Text] [Related]
16. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
17. Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4 cm Well-Differentiated Thyroid Cancer.
Kluijfhout WP; Pasternak JD; Lim J; Kwon JS; Vriens MR; Clark OH; Shen WT; Gosnell JE; Suh I; Duh QY
Thyroid; 2016 Jun; 26(6):820-4. PubMed ID: 27083216
[TBL] [Abstract][Full Text] [Related]
18. Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.
Montgomery KB; Fazendin JM; Chen H; Broman KK
Am J Surg; 2024 Feb; 228():173-179. PubMed ID: 37722937
[TBL] [Abstract][Full Text] [Related]
19. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
[No Abstract] [Full Text] [Related]
20. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]